{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:48:43Z","timestamp":1780548523708,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Canadian Research Initiatives in Substance Misuse"},{"name":"Saskatchewan College of Pharmacy Professionals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-medical use of psychoactive substances is a common harmful behavior that leads to the development of Substance Use Disorders (SUDs). SUD is a significant health concern that causes adverse health consequences and elevates the economic burden on the health care system. SUD treatment plans that utilize a patient-centered approach have demonstrated improved treatment outcomes. It is essential for health care providers, including community pharmacists, to understand patients\u2019 needs and prioritize them. Therefore, this study was conducted to explore the perspective of patients living with SUDs or who used substances non-medically regarding community pharmacist services and the delivery of services in a community pharmacy setting. The study took place in Saskatoon, a small urban center of Saskatchewan, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Qualitative methodology was used for this research inquiry. Four focus groups were conducted, with a total of 20 individuals who had experienced substance use and accessed community pharmacy services. The discussion of the four focus groups was transcribed verbatim and analyzed independently by two researchers. Agreement on the emergent themes was reached through discussion between the two researchers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data analysis resulted in four themes that described participants\u2019 perspectives about community pharmacists. The four emergent themes are: 1) conflicted experiences with community pharmacists, 2) lack of knowledge concerning community pharmacists\u2019 extended services, 3) negative experiences in Opioid Agonist Therapy (OAT) program, and 4) needs from community pharmacists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is significant potential for the patient-pharmacist relationship to address the varying needs of patients who use substances and improve their overall health care experience. Patients who use substances are receptive to pharmacists\u2019 services beyond dispensary; however, respectful communication, provision of drug-related information, and counseling are among the primary demands. Future research should focus on studying the impact of meeting the needs of patients on their treatment outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-021-00374-x","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T07:43:03Z","timestamp":1620027783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Qualitative assessment of patients\u2019 perspectives and needs from community pharmacists in substance use disorder management"],"prefix":"10.1186","volume":"16","author":[{"given":"Sarah","family":"Fatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bakke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"D\u2019Eon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1060-3609","authenticated-orcid":false,"given":"Anas","family":"El-Aneed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"374_CR1","first-page":"37","volume-title":"An integrative perspective on the etiology of substance use","author":"NJ Roberts","year":"2019","unstructured":"Roberts NJ, Fishbein D. An integrative perspective on the etiology of substance use: Prevention of Substance Use: Springer; 2019. p. 37\u201355."},{"issue":"2","key":"374_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jsat.2008.05.008","volume":"36","author":"PK Staiger","year":"2009","unstructured":"Staiger PK, Melville F, Hides L, Kambouropoulos N, Lubman DI. Can emotion-focused coping help explain the link between posttraumatic stress disorder severity and triggers for substance use in young adults? J Subst Abus Treat. 2009;36(2):220\u20136. https:\/\/doi.org\/10.1016\/j.jsat.2008.05.008.","journal-title":"J Subst Abus Treat"},{"key":"374_CR3","unstructured":"Sorge JT, Young M, Maloney-Hall B, Sherk A, Kent P, Zhao J, et al. Estimation of the impacts of substance use on workplace productivity: a hybrid human capital and prevalence-based approach applied to Canada. Can J Public Health. 2019:1\u201310.\u00a0https:\/\/doi.org\/10.10.17269\/s41997-019-00271-8."},{"key":"374_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.psychres.2019.05.038","volume":"278","author":"W Sliedrecht","year":"2019","unstructured":"Sliedrecht W, de Waart R, Witkiewitz K, Roozen HG. Alcohol use disorder relapse factors: a systematic review. Psychiatry Res. 2019;278:97\u2013115. https:\/\/doi.org\/10.1016\/j.psychres.2019.05.038.","journal-title":"Psychiatry Res"},{"issue":"3","key":"374_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.addbeh.2006.06.001","volume":"32","author":"AE Waldrop","year":"2007","unstructured":"Waldrop AE, Back SE, Verduin ML, Brady KT. Triggers for cocaine and alcohol use in the presence and absence of posttraumatic stress disorder. Addict Behav. 2007;32(3):634\u20139. https:\/\/doi.org\/10.1016\/j.addbeh.2006.06.001.","journal-title":"Addict Behav"},{"issue":"1","key":"374_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.evalprogplan.2008.09.003","volume":"32","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Cao D, Guerrero E, Shin H-C. Need-service matching in substance abuse treatment: racial\/ethnic differences. Evaluation and Program Planning. 2009;32(1):43\u201351. https:\/\/doi.org\/10.1016\/j.evalprogplan.2008.09.003.","journal-title":"Evaluation and Program Planning"},{"issue":"3","key":"374_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0740-5472(02)00229-5","volume":"22","author":"BD Smith","year":"2002","unstructured":"Smith BD, Marsh JC. Client-service matching in substance abuse treatment for women with children. J Subst Abus Treat. 2002;22(3):161\u20138. https:\/\/doi.org\/10.1016\/S0740-5472(02)00229-5.","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"374_CR8","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.japh.2017.02.006","volume":"57","author":"JP Bratberg","year":"2017","unstructured":"Bratberg JP. Opioids, naloxone, and beyond: the intersection of medication safety, public health, and pharmacy. J Am Pharm Assoc. 2017;57(2):S5\u20137. https:\/\/doi.org\/10.1016\/j.japh.2017.02.006.","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"374_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1759-8893.2011.00074.x","volume":"3","author":"CO Agomo","year":"2012","unstructured":"Agomo CO. The role of community pharmacists in public health: a scoping review of the literature. J Pharm Health Serv Res. 2012;3(1):25\u201333. https:\/\/doi.org\/10.1111\/j.1759-8893.2011.00074.x.","journal-title":"J Pharm Health Serv Res"},{"issue":"3","key":"374_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0897190009336668","volume":"23","author":"BL Armor","year":"2010","unstructured":"Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250\u201364. https:\/\/doi.org\/10.1177\/0897190009336668.","journal-title":"J Pharm Pract"},{"issue":"3","key":"374_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1715163513488322","volume":"146","author":"K Lynas","year":"2013","unstructured":"Lynas K. Pharmacists can play a key role in implementing new national strategy to combat prescription drug abuse. Can Pharm J\/Revue des Pharmaciens du Canada. 2013;146(3):128\u20139. https:\/\/doi.org\/10.1177\/1715163513488322.","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada."},{"key":"374_CR12","doi-asserted-by":"publisher","unstructured":"Cobaugh DJ. Pharmacist's role in preventing and treating substance abuse: why are wedoing so little? Am Soc Health-System Pharm. 2003;60.\u00a0https:\/\/doi.org\/10.1056\/NEJM199009203231230.","DOI":"10.1056\/NEJM199009203231230"},{"issue":"1","key":"374_CR13","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1331\/JAPhA.2014.13101","volume":"54","author":"Association AP","year":"2014","unstructured":"Association AP. Pharmacists\u2019 role in addressing opioid abuse, addiction, and diversion. J Am Pharm Assoc. 2014;54(1):e5\u2013e15. https:\/\/doi.org\/10.1331\/JAPhA.2014.13101.","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"374_CR14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/pubmed\/fdm064","volume":"29","author":"C Matheson","year":"2007","unstructured":"Matheson C, Bond CM, Tinelli M. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland. J Public Health. 2007;29(4):350\u20137. https:\/\/doi.org\/10.1093\/pubmed\/fdm064.","journal-title":"J Public Health"},{"issue":"6","key":"374_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s11524-009-9400-5","volume":"86","author":"S Vorobjov","year":"2009","unstructured":"Vorobjov S, Uusk\u00fcla A, Abel-Ollo K, Talu A, Des JD. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. J Urban Health. 2009;86(6):918\u201328. https:\/\/doi.org\/10.1007\/s11524-009-9400-5.","journal-title":"J Urban Health"},{"issue":"2","key":"374_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1715163518816726","volume":"152","author":"S Fatani","year":"2019","unstructured":"Fatani S, Dobson R, El-Aneed A. Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorder. Can Pharm J\/Revue des Pharmaciens du Canada. 2019;152(2):117\u201329. https:\/\/doi.org\/10.1177\/1715163518816726.","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada."},{"issue":"6","key":"374_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1465-3362.2010.00234.x","volume":"29","author":"R Dhital","year":"2010","unstructured":"Dhital R, Whittlesea CM, Norman IJ, Milligan P. Community pharmacy service users' views and perceptions of alcohol screening and brief intervention. Drug Alcohol Rev. 2010;29(6):596\u2013602. https:\/\/doi.org\/10.1111\/j.1465-3362.2010.00234.x.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"374_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.sapharm.2013.07.006","volume":"10","author":"W Gidman","year":"2014","unstructured":"Gidman W, Coomber R. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the west of Scotland. Res Soc Adm Pharm. 2014;10(3):576\u201387. https:\/\/doi.org\/10.1016\/j.sapharm.2013.07.006.","journal-title":"Res Soc Adm Pharm"},{"key":"374_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310. https:\/\/doi.org\/10.1016\/j.drugpo.2018.04.004.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"374_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/16066359.2010.507893","volume":"19","author":"J Pulford","year":"2011","unstructured":"Pulford J, Adams P, Sheridan J. What do clients want from alcohol and other drug treatment services? A mixed methods examination. Addict Res Theory. 2011;19(3):224\u201334. https:\/\/doi.org\/10.3109\/16066359.2010.507893.","journal-title":"Addict Res Theory"},{"issue":"4","key":"374_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0740-5472(98)00037-3","volume":"16","author":"Y-I Hser","year":"1999","unstructured":"Hser Y-I, Polinsky ML, Maglione M, Anglin MD. Matching clients\u2019 needs with drug treatment services. J Subst Abus Treat. 1999;16(4):299\u2013305. https:\/\/doi.org\/10.1016\/S0740-5472(98)00037-3.","journal-title":"J Subst Abus Treat"},{"issue":"3","key":"374_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.15288\/jsad.2008.69.449","volume":"69","author":"BE Perron","year":"2008","unstructured":"Perron BE, Ilgen MA, Hasche L, Howard MO. Service needs of clients in outpatient substance-use disorder treatment: a latent class analysis. J Stud Alcohol Drugs. 2008;69(3):449\u201353. https:\/\/doi.org\/10.15288\/jsad.2008.69.449.","journal-title":"J Stud Alcohol Drugs"},{"key":"374_CR23","unstructured":"Thomson L. A review of needle exchange programs in Saskatchewan: final report: Prepared for Population Health Branch. Regina: Saskatchewan Ministry of Health; 2008."},{"issue":"6","key":"374_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.15171\/ijhpm.2015.73","volume":"4","author":"E Jozaghi","year":"2015","unstructured":"Jozaghi E, Jackson A. Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs. Int J Health Policy Manag. 2015;4(6):373\u20139. https:\/\/doi.org\/10.15171\/ijhpm.2015.73.","journal-title":"Int J Health Policy Manag"},{"issue":"5","key":"374_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health Ment Health Serv Res. 2015;42(5):533\u201344. https:\/\/doi.org\/10.1007\/s10488-013-0528-y.","journal-title":"Adm Policy Ment Health Ment Health Serv Res"},{"issue":"6","key":"374_CR26","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/fampra\/13.6.522","volume":"13","author":"MN Marshall","year":"1996","unstructured":"Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522\u20136. https:\/\/doi.org\/10.1093\/fampra\/13.6.522.","journal-title":"Fam Pract"},{"issue":"1\u20134","key":"374_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/01459740.1994.9966115","volume":"16","author":"J Coreil","year":"1994","unstructured":"Coreil J. Group interview methods in community health research. Med Anthropol. 1994;16(1\u20134):193\u2013210. https:\/\/doi.org\/10.1080\/01459740.1994.9966115.","journal-title":"Med Anthropol"},{"issue":"4","key":"374_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1079\/PNS2004399","volume":"63","author":"F Rabiee","year":"2004","unstructured":"Rabiee F. Focus-group interview and data analysis. Proc Nutr Soc. 2004;63(4):655\u201360. https:\/\/doi.org\/10.1079\/PNS2004399.","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"374_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/fampra\/19.3.278","volume":"19","author":"PL Twohig","year":"2002","unstructured":"Twohig PL, Putnam W. Group interviews in primary care research: advancing the state of the art or ritualized research? Fam Pract. 2002;19(3):278\u201384. https:\/\/doi.org\/10.1093\/fampra\/19.3.278.","journal-title":"Fam Pract"},{"issue":"14","key":"374_CR30","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3109\/10826084.2013.800116","volume":"48","author":"C Kuo","year":"2013","unstructured":"Kuo C, Schonbrun YC, Zlotnick C, Bates N, Todorova R, Kao JC-W, et al. A qualitative study of treatment needs among pregnant and postpartum women with substance use and depression. Substance Use Misuse. 2013;48(14):1498\u2013508. https:\/\/doi.org\/10.3109\/10826084.2013.800116.","journal-title":"Substance Use Misuse"},{"issue":"1","key":"374_CR31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10597-018-0271-7","volume":"55","author":"V Zupan\u010di\u010d","year":"2019","unstructured":"Zupan\u010di\u010d V, Pahor M, Kogov\u0161ek T. Focus group in community mental health research: need for adaption. Community Ment Health J. 2019;55(1):168\u201379. https:\/\/doi.org\/10.1007\/s10597-018-0271-7.","journal-title":"Community Ment Health J"},{"key":"374_CR32","volume-title":"Focus groups as qualitative research: sage publications","author":"DL Morgan","year":"1996","unstructured":"Morgan DL. Focus groups as qualitative research: sage publications; 1996."},{"issue":"7000","key":"374_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.311.7000.299","volume":"311","author":"J Kitzinger","year":"1995","unstructured":"Kitzinger J. Qualitative research: introducing focus groups. Bmj. 1995;311(7000):299\u2013302. https:\/\/doi.org\/10.1136\/bmj.311.7000.299.","journal-title":"Bmj."},{"issue":"4","key":"374_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00006199-196807000-00014","volume":"17","author":"BG Glaser","year":"1968","unstructured":"Glaser BG, Strauss AL, Strutzel E. The discovery of grounded theory; strategies for qualitative research. Nurs Res. 1968;17(4):364. https:\/\/doi.org\/10.1097\/00006199-196807000-00014.","journal-title":"Nurs Res"},{"issue":"1","key":"374_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","volume":"62","author":"S Elo","year":"2008","unstructured":"Elo S, Kyng\u00e4s H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107\u201315. https:\/\/doi.org\/10.1111\/j.1365-2648.2007.04569.x.","journal-title":"J Adv Nurs"},{"issue":"1","key":"374_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13722-018-0110-8","volume":"13","author":"J McNeely","year":"2018","unstructured":"McNeely J, Kumar PC, Rieckmann T, Sedlander E, Farkas S, Chollak C, et al. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff. Addict Sci Clin Pract. 2018;13(1):8. https:\/\/doi.org\/10.1186\/s13722-018-0110-8.","journal-title":"Addict Sci Clin Pract"},{"issue":"1\u20132","key":"374_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC Van Boekel","year":"2013","unstructured":"Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.02.018.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"374_CR38","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/hex.12401","volume":"19","author":"HL Hattingh","year":"2016","unstructured":"Hattingh HL, Emmerton L. Ng Cheong tin P, Green C. utilization of community pharmacy space to enhance privacy: a qualitative study. Health Expect. 2016;19(5):1098\u2013110. https:\/\/doi.org\/10.1111\/hex.12401.","journal-title":"Health Expect"},{"issue":"3","key":"374_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1369-7625.2004.00274.x","volume":"7","author":"C Anderson","year":"2004","unstructured":"Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990\u20132002. Health Expect. 2004;7(3):191\u2013202. https:\/\/doi.org\/10.1111\/j.1369-7625.2004.00274.x.","journal-title":"Health Expect"},{"issue":"4","key":"374_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1715163514535731","volume":"147","author":"DV Kelly","year":"2014","unstructured":"Kelly DV, Young S, Phillips L, Clark D. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services. Can Pharm J\/Revue des Pharmaciens du Canada. 2014;147(4):239\u201347. https:\/\/doi.org\/10.1177\/1715163514535731.","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada"},{"issue":"8","key":"374_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.sapharm.2017.12.009","volume":"15","author":"WM Compton","year":"2019","unstructured":"Compton WM, Jones CM, Stein JB, Wargo EM. Promising roles for pharmacists in addressing the US opioid crisis. Res Soc Adm Pharm. 2019;15(8):910\u20136. https:\/\/doi.org\/10.1016\/j.sapharm.2017.12.009.","journal-title":"Res Soc Adm Pharm"},{"issue":"9","key":"374_CR42","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1345\/aph.1E456","volume":"39","author":"EJ Jones","year":"2005","unstructured":"Jones EJ, MacKinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527\u201333. https:\/\/doi.org\/10.1345\/aph.1E456.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"374_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.sapharm.2016.04.001","volume":"13","author":"M Sabater-Galindo","year":"2017","unstructured":"Sabater-Galindo M, de Maya SR, Benrimoj SI, Gastelurrutia MA, Mart\u00ednez-Mart\u00ednez F, Sabater-Hern\u00e1ndez D. Patients' expectations of the role of the community pharmacist: development and testing of a conceptual model. Res Soc Adm Pharm. 2017;13(2):313\u201320. https:\/\/doi.org\/10.1016\/j.sapharm.2016.04.001.","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"374_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.sapharm.2006.03.003","volume":"3","author":"MM Worley","year":"2007","unstructured":"Worley MM, Schommer JC, Brown LM, Hadsall RS, Ranelli PL, Stratton TP, et al. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script? Res Soc Adm Pharm. 2007;3(1):47\u201369. https:\/\/doi.org\/10.1016\/j.sapharm.2006.03.003.","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"374_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.sapharm.2005.09.006","volume":"1","author":"LM Guirguis","year":"2005","unstructured":"Guirguis LM, Chewning BA. Role theory: literature review and implications for patient-pharmacist interactions. Res Soc Adm Pharm. 2005;1(4):483\u2013507. https:\/\/doi.org\/10.1016\/j.sapharm.2005.09.006.","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"374_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/00952991003736371","volume":"36","author":"SM Kelly","year":"2010","unstructured":"Kelly SM, O'Grady KE, Brown BS, Mitchell SG, Schwartz RP. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010;36(3):150\u20134. https:\/\/doi.org\/10.3109\/00952991003736371.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"374_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0740-5472(98)00076-2","volume":"17","author":"R Fiorentine","year":"1999","unstructured":"Fiorentine R, Nakashima J, Anglin MD. Client engagement in drug treatment. J Subst Abus Treat. 1999;17(3):199\u2013206. https:\/\/doi.org\/10.1016\/S0740-5472(98)00076-2.","journal-title":"J Subst Abus Treat"},{"issue":"4","key":"374_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0740-5472(96)00109-2","volume":"13","author":"R Fiorentine","year":"1996","unstructured":"Fiorentine R, Anglin MD. More is better: counseling participation and the effectiveness of outpatient drug treatment. J Subst Abus Treat. 1996;13(4):341\u20138. https:\/\/doi.org\/10.1016\/S0740-5472(96)00109-2.","journal-title":"J Subst Abus Treat"},{"issue":"8","key":"374_CR49","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1360-0443.2004.00772.x","volume":"99","author":"PD Friedmann","year":"2004","unstructured":"Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. The effect of matching comprehensive services to patients\u2019 needs on drug use improvement in addiction treatment. Addiction. 2004;99(8):962\u201372. https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00772.x.","journal-title":"Addiction."},{"issue":"6","key":"374_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0740-5472(97)00181-5","volume":"14","author":"DD Simpson","year":"1997","unstructured":"Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention. J Subst Abus Treat. 1997;14(6):565\u201372. https:\/\/doi.org\/10.1016\/S0740-5472(97)00181-5.","journal-title":"J Subst Abus Treat"},{"key":"374_CR51","volume-title":"Treating drug problems: a study of the evolution, effectiveness, and financing of public and private drug treatment systems (Vol. 1)","author":"DR Gerstein","year":"1990","unstructured":"Gerstein DR, Harwood HJ. Treating drug problems: a study of the evolution, effectiveness, and financing of public and private drug treatment systems (Vol. 1). Washington, DC: Institute of Medicine; 1990."},{"issue":"1","key":"374_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.mlr.0000188913.50489.77","volume":"44","author":"PD Friedmann","year":"2006","unstructured":"Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006;44(1):8\u201315. https:\/\/doi.org\/10.1097\/01.mlr.0000188913.50489.77.","journal-title":"Med Care"},{"issue":"3","key":"374_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jsat.2005.11.006","volume":"30","author":"JL Pringle","year":"2006","unstructured":"Pringle JL, Emptage NP, Hubbard RL. Unmet needs for comprehensive services in outpatient addiction treatment. J Subst Abus Treat. 2006;30(3):183\u20139. https:\/\/doi.org\/10.1016\/j.jsat.2005.11.006.","journal-title":"J Subst Abus Treat"},{"issue":"9","key":"374_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/15265160903090066","volume":"9","author":"D Buchman","year":"2009","unstructured":"Buchman D, Reiner PB. Stigma and addiction: being and becoming. Am J Bioeth. 2009;9(9):18\u20139. https:\/\/doi.org\/10.1080\/15265160903090066.","journal-title":"Am J Bioeth"},{"issue":"4","key":"374_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1176\/ps.2010.61.4.373","volume":"61","author":"A Interian","year":"2010","unstructured":"Interian A, Ang A, Gara MA, Link BG, Rodriguez MA, Vega WA. Stigma and depression treatment utilization among Latinos: utility of four stigma measures. Psychiatric services (Washington, DC). 2010;61(4):373.","journal-title":"Psychiatric services (Washington, DC)"},{"issue":"2","key":"374_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09595230500102434","volume":"24","author":"R Room","year":"2005","unstructured":"Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143\u201355. https:\/\/doi.org\/10.1080\/09595230500102434.","journal-title":"Drug Alcohol Rev"},{"key":"374_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.02.019","volume":"162","author":"LR Smith","year":"2016","unstructured":"Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016;162:34\u201343. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.019.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"374_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1360-0443.2002.00083.x","volume":"97","author":"PL Dobkin","year":"2002","unstructured":"Dobkin PL, Civita MD, Paraherakis A, Gill K. The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers. Addiction. 2002;97(3):347\u201356. https:\/\/doi.org\/10.1046\/j.1360-0443.2002.00083.x.","journal-title":"Addiction."},{"key":"374_CR59","first-page":"117822181983337","volume":"13","author":"H Pettersen","year":"2019","unstructured":"Pettersen H, Landheim A, Skeie I, Biong S, Brodahl M, Oute J, et al. How social relationships influence substance use disorder recovery: a collaborative narrative study. Substance Abuse: Res Treatment. 2019;13:1178221819833379.","journal-title":"Substance Abuse: Res Treatment"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-021-00374-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T19:32:11Z","timestamp":1626809531000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00374-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-79421\/v1","asserted-by":"object"}]},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"14 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted after the ethical approval from the University of Saskatchewan Ethics Board (Beh#16\u2013256). Participants provided their signed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}